drugset / Trial / NCT07367542

Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery

NCT07367542

RandomizedParallel-groupTriple-blindTreatment

Summary

A Dual-Center, Randomized, Controlled, Blinded, Prospective Study on the Effects of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery

Timeline

Start
2026-01-17
Primary completion
2027-02-01
Completion
2027-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.3 mg/kg Intravenous